
1. int j infect dis. 2019 may;82:111-116. doi: 10.1016/j.ijid.2019.02.025. epub 2019
feb 25.

cytochrome p450 cyp2b6*6 distribution among congolese individuals hiv,
tuberculosis malaria infection.

peko sm(1), gueye nsg(2), vouvoungui c(3), koukouikila-koussounda f(4), kobawila 
sc(5), nderu d(6), velavan tp(7), ntoumi f(8).

author information: 
(1)fondation congolaise pour la recherche médicale (fcrm), brazzaville, congo;
faculty sciences technology, university marien ngouabi, brazzaville,
congo. electronic address: simonmarie8peko@gmail.com.
(2)fondation congolaise pour la recherche médicale (fcrm), brazzaville, congo;
faculty sciences technology, university marien ngouabi, brazzaville,
congo. electronic address: ngampio@gmail.com.
(3)fondation congolaise pour la recherche médicale (fcrm), brazzaville, congo;
faculty sciences technology, university marien ngouabi, brazzaville,
congo. electronic address: vjchristevy@gmail.com.
(4)fondation congolaise pour la recherche médicale (fcrm), brazzaville, congo;
faculty sciences technology, university marien ngouabi, brazzaville,
congo. electronic address: felixkoukouikila@yahoo.fr.
(5)faculty sciences technology, university marien ngouabi, brazzaville,
congo. electronic address: kobawila.simon@gmail.com.
(6)institute tropical medicine, university tübingen, tübingen, germany.
electronic address: dnderu@gmail.com.
(7)fondation congolaise pour la recherche médicale (fcrm), brazzaville, congo;
institute tropical medicine, university tübingen, tübingen, germany;
faculty medicine, duy tan university, da nang, vietnam. electronic address:
velavan@medizin.uni-tuebingen.de.
(8)fondation congolaise pour la recherche médicale (fcrm), brazzaville, congo;
faculty sciences technology, university marien ngouabi, brazzaville,
congo; institute tropical medicine, university tübingen, tübingen, germany.
electronic address: ffntoumi@hotmail.com.

background: cytochrome p450 cyp2b6*6 (cyp2b6 c.516g>t; rs3745274) one of
the genetic factors alters drug metabolism antimalarial,
antiretroviral tb first-line drugs. central african populations, the
distribution cyp2b6*6 variant poorly documented. study
investigated distribution cyp2b6 c.516g>t variant among congolese
individuals.
methods: total 418 patients hiv-1 mono-infection, hiv-1 and
tuberculosis coinfection symptomatic p. falciparum malaria genotyped for
the cyp2b6 c.516g>t snp using restriction fragment length polymorphism (rflp).
the allele frequencies genotype distributions determined.
results: cyp2b6 c.516g>t successfully analysed 69% (288/418) the
study participants. among investigated individuals, distribution the
major allele cyp2b6*g 45% minor cyp2b6*t allele 55%. significant 
differences genotype distribution also observed among studied
individuals. cyp2b6*gg (rapid metabolizer) genotype observed 17%
(49/288) followed cyp2b6*gt (intermediate metabolizer) 55% (159/288) and
cyp2b6*tt (poor metabolizers) 28% (80/288).
conclusion: study contributes increasing understanding population
pharmacogenetics may help policy makers regulate treatment guidelines 
congolese population high burden hiv, malaria tb.

copyright © 2019. published elsevier ltd.

doi: 10.1016/j.ijid.2019.02.025 
pmid: 30818046  [indexed medline]

